Cargando…
Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient’s Activity Level
BACKGROUND: Livedoid vasculopathy (LV) is a rare disease characterized by livedo racemosa, atrophie blanche, ulcerations, and severe pain. Low molecular weight heparins and rivaroxaban can be used in LV-patients. In addition, intravenous immunoglobulins (IVIG) have been described as treatment-option...
Autores principales: | Kofler, Katrin, Strölin, Anke, Geiger, Vanessa, Kofler, Lukas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474298/ https://www.ncbi.nlm.nih.gov/pubmed/33779349 http://dx.doi.org/10.1177/12034754211003525 |
Ejemplares similares
-
Efficacy and safety of intravenous immunoglobulin for treating
refractory livedoid vasculopathy: a systematic review
por: Gao, Yimeng, et al.
Publicado: (2022) -
Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin
por: Yoshioka, Katsunobu, et al.
Publicado: (2018) -
Dermoscopic features of livedoid vasculopathy
por: Hu, Stephen Chu-Sung, et al.
Publicado: (2017) -
Comparative Efficacy of Rivaroxaban and Immunoglobulin Therapy in the Treatment of Livedoid Vasculopathy: A Systematic Review
por: Ramphall, Shivana, et al.
Publicado: (2022) -
Successful treatment of livedoid vasculopathy with rivaroxaban
por: Evans, John M., et al.
Publicado: (2015)